Genuity Science Investor

Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.

Invests into

Headquarters: Boston, Massachusetts, United States
Last Funding Type: Series C
Investors Number: 8.0
Last Funding Date: 2018-11-27
Acquisitions Number: Made Acquisitions, Was Acquired
Employee Number: 101-250
Total Funding: 455000000.0
Founded Date: 2013-01-01
Technology: Cancer
Estimated Revenue: $10M to $50M
Zip: NA
Industry: End-to-End Drug Development
Funding Status: M&A